CIK 0001641281 · <br>Emerging growth company
Bolt Biotherapeutics, Inc.
Sign in to watch- Ticker
- BOLT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 472804636
- Phone
- 650-665-9295
- Business address
- 900 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- Bolt Therapeutics, Inc.
- 4 Open-market buy 10% owner bought 450,000 shares at $20.00 ($9,000,000)
- 8-K Event Bylaws or fiscal year change
- 4 Open-market buy 10% owner bought 350,000 shares at $20.00 ($7,000,000)
- 4 Open-market buy Director bought 1,200 shares at $20.00 ($24,000)
- 4 Open-market sale Director sold 62 shares at $20.00 ($1,240)
- 4 Open-market buy Director bought 450,000 shares at $20.00 ($9,000,000)
- 4 Open-market buy Director bought 2,200 shares at $20.00 ($44,000)
- 4 Open-market buy Director bought 200,000 shares at $20.00 ($4,000,000)
- 4 Open-market buy Chief Financial Officer bought 1,200 shares at $20.00 ($24,000)
- 4 Open-market buy Chief Executive Officer bought 1,500 shares at $20.00 ($30,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- S-8 Other Securities Offered to Employees in Benefit Plans
- 424B4 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- S-1MEF Other S-1MEF
- 3 Insider Initial Statement of Ownership
Page 13 of 15 · 297 filings